Evaluation of the effectiveness of remdesivir in treating severe COVID-19 using data from the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, national cohort study
Arch et al., medRxiv, doi:10.1101/2021.06.18.21259072
https://c19early.org/arch.html